Theriva Price To Sales Ratio from 2010 to 2025

Below is the plot of the Price To Sales Ratio of Theriva Biologics over the last few years. Price to Sales Ratio is figured by comparing Theriva Biologics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Theriva Biologics sales, a figure that is much harder to manipulate than other Theriva Biologics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Theriva Biologics' Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Theriva Biologics' overall financial position and show how it may be relating to other accounts over time.